Health Care · Surgical & Medical Instruments & Apparatus · NYSE · CIK 1609550 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $50.02Day −2.06%Mkt cap $1.4BP/E (FY) 10.2×1Y −61.9%Off 52W high −66.0%Vol (1Y) 76.0%
Daily closing price, split-adjusted to the current basis; 3y shown of 2,066 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest15.1% of sh out |
| Days to cover4.2d |
| 13F net flow (QoQ)+12.37% |
| Top-10 13F concentration49.3% |
| Next report (est.)2026-08-03 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| P/E (FY)10.2× |
| Sales (TTM)$915.2M |
| Earnings (TTM)$131.1M |
| ROE19.8% |
| Net margin15.9% |
| ROIC14.2% |
| Sales growth 3Y30.8% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−45.8% |
| 1Y−61.9% |
| 3Y−82.6% |
| 5Y−72.7% |
| Since incept. (ann.)+8.8% |
Total return through 2026-07-30 · series begins 2018-05-03. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)76.0% |
| Ann. volatility (3Y)66.9% |
| Sharpe (1Y)−0.88 |
| Sharpe (3Y)−0.53 |
| Max drawdown (1Y)−72.2% |
| Max drawdown (3Y)−86.2% |
| Beta (3Y vs SPY)0.37 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| BlackRock, Inc. | 3.5M | $183M | — | −0.0% |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 2.7M | $139M | — | +79.5% |
| WELLINGTON MANAGEMENT GROUP LLP | 2.5M | $131M | — | +14.7% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.6M | $84M | — | new |
| MORGAN STANLEY | 1.5M | $75M | — | +15.2% |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.3M | $65M | — | new |
| D. E. Shaw & Co., Inc. | 1.2M | $61M | — | −1.9% |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 1.1M | $59M | — | −2.1% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total. % of shares outstanding suppressed: the summed institutional 13F holdings (34,866,157) exceed the cover-page shares-outstanding count for this quarter (28,589,291, as of 2026-02-05) by more than securities-lending double counting can explain (FINRA short interest 3,187,512 shares at 2026-04-30), so the share count is stale or wrong (common for annual 20-F foreign private issuers after a share issuance) and a percentage would be fabricated. Holder share counts are shown as filed.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-04 | −$0.39 | −490.0% | $204.6M | +1.6% |
| 2025-12-31 | 2026-02-11 | — | — | $269.1M | +12.2% |
| 2025-09-30 | 2025-11-03 | $0.34 | −43.3% | $224.5M | +10.5% |
| 2025-06-30 | 2025-08-04 | −$0.12 | −137.5% | $217.1M | +10.8% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-03 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
Operating 100%
business segments · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
